Delving into the Latest Updates on TRF Pharma, Inc. with Synapse

概览

关联

1

项与 TRF Pharma, Inc. 相关的药物

TRF-1101

靶点-

作用机制-

在研机构-

原研机构

TRF Pharma, Inc.

在研适应症-

非在研适应症

镰状细胞血症 [+2]

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

2

项与 TRF Pharma, Inc. 相关的临床试验

EUCTR2008-003573-41-GB

/ Not yet recruitingN/A

A randomised, double-blind, placebo-controlled study to assess the safety and activity of TRF-1101 on microvascular blood flow, vascular endothelial injury, and vasoocclusive pain in patients with sickle cell disease - A Study of TRF-1101 in Sickle Cell Disease

开始日期2009-01-15

申办/合作机构

TRF Pharma, Inc.

NCT00773890

/ Terminated临床1/2期

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Activity of TRF-1101 on Microvascular Blood Flow, Vascular Endothelial Injury, and Vasoocclusive Pain in Patients With Sickle Cell Disease

This study is designed to assess the safety, tolerability, and activity of TRF-1101 on microvascular blood flow, vascular endothelial injury, and vasoocclusive pain associated with sickle cell disease.

开始日期2008-07-01

申办/合作机构

TRF Pharma, Inc.

100 项与 TRF Pharma, Inc. 相关的临床结果

登录后查看更多信息

0 项与 TRF Pharma, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 TRF Pharma, Inc. 相关的药物交易

登录后查看更多信息

100 项与 TRF Pharma, Inc. 相关的转化医学

登录后查看更多信息